Skip to content
Screener

Tarsus Pharmaceuticals, Inc. TARS Common Stock Shares Issued

Common Stock Shares Issued at other companies

Bausch + Lomb logo
Bausch + LombBLCO
357.1M+0.9%
HRO
HarrowHROW
37.5M+2.1%
Schering-Plough logo
Schering-PloughSGP
2.2M+0.3%
TTR
Turn Therapeutics Inc.TTRX
$29.79M
PTH
Pelthos TherapeuticsPTHS
3.4M

Other financials

Income statement

See full
Revenue$173.9M+69.4%
Gross profit$161.8M+67.8%
Operating income-$19.9M+10.3%
Net income-$18.6M+8.8%
EPS (diluted)-$0.43+10.4%

Balance sheet

See full
Cash & equivalents$206.6M+108%
Total debt$88.8M+22.6%
Total equity$346.7M+4.2%
Total assets$611.1M+23.5%

Cash flow

See full
Operating cash flow$61.2M+308%
CapEx$4.1M+306%
Free cash flow$57.2M+288%

Valuation

See full
Market cap$2.97B+40.7%
Enterprise value$2.86B+36.8%
P/S4.9×-2.2×

Profitability

See full
Gross margin79.8%
Operating margin-8%-3.5pp
Net margin-7.7%-3.3pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-13.7%-4.9pp
Debt / equity0.3×0.0×
Current ratio3.2×-2.1×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:25 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001819790-26-000064

As of June 30, 2026 and December 31, 2025, the Company had 43,271,347 and 42,553,931 shares of common stock issued and outstanding, respectively, which excludes 312,500 of pre-funded warrants that remained exercisable at both period ends and are reserved for future issuance. Common stockholders have one vote for each share of common stock held and are entitled to receive dividends declared by the Company’s Board of Directors when legally available for distribution, then-subject to the dividend rights of the holders of preferred stock.

Item 1. Financial Statements

FAQ

What is Tarsus Pharmaceuticals, Inc.'s common stock shares issued?
Tarsus Pharmaceuticals, Inc. (TARS) reported common stock shares issued of 43.3M in Q2 2026.
How has Tarsus Pharmaceuticals, Inc.'s common stock shares issued changed year-over-year?
Tarsus Pharmaceuticals, Inc.'s common stock shares issued increased by 2.5% year-over-year, from 42.2M to 43.3M.
What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock shares issued?
Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock shares issued has grown at a 15.7% compound annual growth rate (CAGR), from 20.5M to 42.6M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude